Indivior Pharmaceuticals Inc
INDV
Rankning i aktier
#4006
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Aktiekurs
$32.56
Senast synkroniserad: 2026-10-16
Marknadsvärde
$4.06B
Förändring (1 dag)
-3.15%
Förändring (1 år)
33.01%
Land
US
Handel Indivior Pharmaceuticals Inc (INDV)
Kategori
Healthcare
EPS för Indivior Pharmaceuticals Inc (INDV)
EPS per June 2026 TTM: $2.84
Enligt Indivior Pharmaceuticals Incs senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $2.84. Vid slutet av 2023 hade bolaget ett EPS på $0.01, en ökning jämfört med EPS från 2022 som var $-0.37.
EPS-historik för Indivior Pharmaceuticals Inc från 2016 till 2026
EPS vid slutet av varje år
| År | EPS | Ändra |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
EPS för liknande företag eller konkurrenter
| Företag | EPS | EPS-differens | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
